Apollo Endosurgery, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q1 2016 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Apollo Endosurgery, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2016 to Q4 2022.
  • Apollo Endosurgery, Inc. Income Tax Expense (Benefit) for the quarter ending December 31, 2022 was $176K.
  • Apollo Endosurgery, Inc. Income Tax Expense (Benefit) for the twelve months ending December 31, 2022 was $584K, a 274% increase year-over-year.
  • Apollo Endosurgery, Inc. annual Income Tax Expense (Benefit) for 2022 was $584K, a 274% increase from 2021.
  • Apollo Endosurgery, Inc. annual Income Tax Expense (Benefit) for 2021 was $156K, a 9.86% increase from 2020.
  • Apollo Endosurgery, Inc. annual Income Tax Expense (Benefit) for 2020 was $142K, a 48.4% decline from 2019.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $584K $176K +$240K Oct 1, 2022 Dec 31, 2022 10-K 2023-03-30
Q3 2022 $344K $172K +$82K +91.1% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-01
Q2 2022 $262K $49K -$22K -31% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $284K $187K +$128K +217% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-03
Q4 2021 $156K -$64K -$116K -223% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $272K $90K +$49K +120% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $223K $71K +$65K +1083% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $158K $59K +$16K +37.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $142K $52K -$92K -63.9% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-22
Q3 2020 $234K $41K -$39K -48.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-01
Q2 2020 $273K $6K +$6K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $267K $43K -$8K -15.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $275K $144K +$75K +109% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 $200K $80K +$44K +122% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $156K $0 -$28K -100% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $184K $51K -$7K -12.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-04
Q4 2018 $191K $69K -$67K -49.3% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-26
Q3 2018 $258K $36K -$19K -34.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-30
Q2 2018 $277K $28K -$35K -55.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-24
Q1 2018 $312K $58K +$8K +16% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 $304K $136K -$48K -26.1% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 $352K $55K +$51K +1275% Jul 1, 2017 Sep 30, 2017 10-Q/A 2018-11-13
Q2 2017 $301K $63K -$37K -37% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $338K $50K -$49K -49.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
Q4 2016 $387K $184K Oct 1, 2016 Dec 31, 2016 10-K 2018-03-01
Q3 2016 $4K Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-26
Q2 2016 $100K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-01
Q1 2016 $99K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.